Morgan Corbin, PharmD, CPP, BCOP, obtained her BA in biology from Carson-Newman University (2011) and her Doctor of Pharmacy (2016) from Bill Gatton College of Pharmacy at East Tennessee State University. She then went on to complete postgraduate residency training at University Health Shreveport (PGY1 - 2017) and Novant Health Cancer Specialists (PGY2 Oncology - 2018). Upon completion of postgraduate training she received her board certification in oncology pharmacy. She works as a clinical pharmacist practitioner at the Cancer Center at Novant Health New Hanover Regional Medical Center.
Recent WebMD content from Morgan Corbin, PharmD, CPP, BCOP
- Bortezomib (Velcade, Boruzu)
- Tecentriq Hybreza (atezolizumab/hyaluronidase-tqjs)
- Jakafi (ruxolitinib)
- Vonjo (pacritinib)
- Jaypirca (pirtobrutinib)
- Inrebic (fedratinib)
- Tecentriq (atezolizumab)
- Ninlaro (ixazomib)
- Kyprolis (carfilzomib)
- Orgovyx (relugolix)
- Xofigo (radium Ra 223 dichloride)
- Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
- Retevmo (selpercatinib)
- Tagrisso (osimertinib)
- How Tagrisso Works for Lung Cancer
- Retevmo: Targeted Therapy for Lung Cancer Treatment
- How Does Enhertu Work for Breast Cancer?